retatrutide glp-1 gip glucagon triple agonist Summer is coming, and peptides are blowing up. is a GLP 3 not a GLP1 like ozempic or Wagovey 🚀 “GLP-3” (Next-Generation / Triple-Agonist Class) Example: Retatrutide What makes it different Structural insights into the triple

Over a longer 2-year trial, the rate of GI adverse events climbed to 82% on semaglutide (source)

Therefore, therapeutic options that could work in a way other than classic antidepressants are being sought to increase the effectiveness of the treatment

Do not freeze your Pen

Many people wonder if they can obtain GLP-1 (glucagon-like peptide-1) directly from foods, especially given the popularity of GLP-1 medications like Ozempic and Wegovy for diabetes and weight management

No significant differences in secondary outcomes were observed post-weighting, and all results were consistent across multiple sensitivity analyses

Since 2005, multiple GLP-1R agonists resembling exendin-4 have been developed ( Figure 2 ), with fatty-acid modifications to increase half-life and facilitate less frequent dosing regimes